Merit Medical Systems (MMSI) said Tuesday it has bought Biolife Delaware for about $120 million.
The acquisition will likely add about $18 million of revenue on an annualized basis starting in fiscal 2026, with a mid-teens growth and accretive non-GAAP margin and profitability profile, Merit Medical Systems said.